Other

OCI Unrealized Holding Gain (Loss) on Securities, Net of Tax

Kailera Therapeutics OCI Unrealized Holding Gain (Loss) on Securities, Net of Tax decreased by 12583.3% to -$761.00K in Q1 2026 compared to the prior quarter.

Analysis

StatementIncome Statement
SectionOther
First reportedQ1 2025
Last reportedQ1 2026May 26, 2026
Metric ID: cop_oci_unrealized_holding_gain_loss_on_securities_net_of_tax

Historical Data

2 periods
 Q1 '25Q1 '26
Value-$6.00K-$761.00K
QoQ Change—<-999%
YoY Change—<-999%
Range-$761.00K – -$6.00K
Avg YoY Growth<-999%
Median YoY Growth<-999%

Frequently Asked Questions

What is Kailera Therapeutics 's oci unrealized holding gain (loss) on securities, net of tax?
Kailera Therapeutics (KLRA) reported oci unrealized holding gain (loss) on securities, net of tax of -$761.00K in Q1 2026.